The levels of GCDCA-S, another bile acid previously proposed as an OATP1B substrate, were also modestly increased in manner dependent on the paclitaxel dose ( Figure 3 E), although the differences did not reach statistical significance ( Figure 3 F).
← all excerpts
A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug-Drug Interaction Liabilities.
1
—
—